Surgery for symptomatic hyperparathyroidism remains the standard thera
py. Asymptomatic primary hyperparathyroidsm (pHPT) is being diagnosed
with increasing frequency owing to broad serum testing. Indications fo
r surgery in this setting are controversial. For evaluation of surgica
l safety we performed a retrospective analysis of our patients who wer
e being operated on for asymptomatic pHPT. From January 1988 until Aug
ust 1995, 243 patients were treated for pHPT and registered prospectiv
ely at our unit. Seventy-six patients were classified as asymptomatic.
In all, 75% of the patients were female; the mean age was 62 years. I
n this group, 87% of the patients had cervical sonography in order to
localize the adenoma. Highly selective venous catheterization was requ
ired in cervical reexplorations. Statistical analysis for potential pr
ognostic factors for the clinical outcome was performed. Successful ce
rvical exploration was possible in 71 patients (94.7%). With 4 patient
s remaining hypercalcemic, the rate of persistency was 5.2%. Localizat
ion procedures were correct in 58% for cervical ultrasound and 77% for
selective venous catheterization. Postoperative morbidity included on
e permanent recurrent laryngeal nerve palsy and 2 patients with hemorr
hage who were treated by reoperation. While one case of permanent hypo
parathyroidism was well controlled by oral supplementation, 18 patient
s recovered from temporary hypoparathyroidism. No postoperative mortal
ity occurred. Risk factor analysis revealed only cervical reexploratio
ns for HPT to be associated with a higher morbidity (P = 0.02). Surger
y for asymptomatic pHPT can be performed with reasonable safety. Cervi
cal reexplorations in asymptomatic patients should be reserved for spe
cial indications. Apart from this small group, all patients should be
evaluated for surgery.